If your doctor has recorded any of the following symptoms while you were taking Benicar, you should contact us right away for a free consultation at 877.292.1500.
According to a recent U.S. Food and Drug Administration (FDA) warning, taking Benicar (Olmesartan medoxomil), a medication prescribed for the treatment of high blood pressure (hypertension), can result in a gastrointestinal problem referred to as sprue-like enteropathy, which is characterized by chronic diarrhea, unexplained weight loss, vomiting, severe pain, and a number of other gastrointestinal problems. As a result, recently patients who have suffered these symptoms while taking Benicar have begun seeking legal help by filing Benicar Lawsuits.
Benicar is a medication approved for the high blood pressure treatment, either alone or with other antihypertensive agents. Until the recent FDA warning, Benicar’s product label did not warn users about the risk of sprue-like enteropathy. The FDA has stated that the benefits of this medication still outweigh its probable dangers when used to treat high blood pressure, but users are vulnerable to Benicar’s adverse side effects. In addition, the FDA mentioned in its warning that none of the other medications prescribed for the treatment of high blood pressure have this severely adverse side effect
The relationship between Benicar and sprue-like enteropathy was initially noticed in 2012. Mayo Clinic research experts established that over a duration of three years, 22 patients experienced symptoms resembling Celiac Disease while taking Benicar. Nonetheless, blood tests from the individuals did not indicate a these patients had Celiac Disease. When the patients were placed on a gluten-free diet (the treatment for Celiac Disease), they did not respond and showed no change in their symptoms. When the patients quit taking Benicar, their gastrointestinal problems improved and they began gaining weight, according to one of the researchers. A few months later, another study established a link between olmesartan and another forty cases of celiac disease.
In 2013, the FDA asked for more warnings on the label for Benicar, describing the risk of chronic diarrhea, referred to as sprue-like entropathy. The symptoms may ease when the drug is not used again, but users may endure lifelong gastrointestinal problems and severe malnourishment.
Any person who has taken this medication and has experienced its adverse side effects may be entitled to file a Benicar lawsuit against Daiichi Sankyo, Inc. If you or someone you know has taken Benicar, or any other drug with olmesartan in it, and experienced the adverse side effects described above, call the Abbott Law Group at 877.292.1500 (or fill out the online form) to receive a free, confidential case evaluation. The Abbot Law Group has an experienced team of lawyers and has been handling litigations and trials for more than 30 years. If your case meets the criteria for eligibility to file a Benicar lawsuit, the Abbott Law Group will fight to obtain the maximum compensation to which you may be legally entitled.